Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage migration inhibitory factor (MIF) is a multifunctional protein with key roles in immunity, inflammation, and disease pathogenesis. It acts as both an immunoregulatory cytokine and proinflammatory mediator, promoting the production/release of other proinflammatory cytokines and counteracting the anti-inflammatory effects of glucocorticoids. It also possesses enzymatic activity and promotes tumorigenesis through several mechanisms, including sustained ERK1/2 activation, antagonism of p53-mediated apoptosis, activation of HIF‑1α under hypoxic conditions, and downregulation of NK cell receptor NKG2D. Elevated levels are associated with various cancers and inflammatory diseases, making it a promising biomarker candidate and therapeutic target.
Inhibition of MIF activity; modulation of cytokine secretion; counteraction of glucocorticoid effects; antagonism of p53-mediated apoptosis; inhibition of NK cell receptor NKG2D impairing tumor surveillance by NK cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage Migration Inhibitory Factor (None).